title: Evolution of glucose induced thermogenesis in obese subjects with and without diabetes: a six-year follow-up study.
abstract: The thermogenic response to a 100 g oral glucose load was measured prospectively (by indirect calorimetry) in three groups of obese subjects: (1) normal glucose tolerance (n = 12, initial weight 86.4 +/- 3.9 kg, BMI 30.4 +/- 1.1 kg/m2; (2) impaired glucose tolerance (n = 8, initial weight 105.3 +/- 7.6 kg, body mass index (BMI) 37.6 +/- 2.9 kg/m2; (3) diabetes (n = 12), initial weight 102.1 +/- 5.3 kg, BMI 36.2 +/- 2.0 kg/m2). The thermogenic response to glucose averaged 6.8 +/- 1.1 and 7.0 +/- 1.0 per cent, in the two non-diabetic obese groups respectively, and was significantly lower in the obese diabetic group (3.1 +/- 0.8 per cent). With the evolution of obesity (i.e. 6 years later), the glucose-induced thermogenesis (GIT) was significantly reduced in the non-diabetic groups (P less than 0.05) to 4.1 +/- 0.8 and 3.0 +/- 1.1 per cent respectively, and was still blunted in the diabetic group (2.1 +/- 0.7 per cent). The decrease in GIT was accompanied by a reduction in glucose tolerance and insulin response with no change in fasting plasma insulin. These effects were observed despite the fact that the body weight of the subject did not change significantly over the 6-year period. It is concluded that the decrease in GIT which accompanies the worsening of glucose tolerance and the occurrence of diabetes is a mechanism which may contribute to maintain the obesity state by a reduction of energy expenditure.
authors.affiliation: Department of Internal Medicine, Lausanne University Hospital, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Golay
authors.forename: D
authors.initials: D
authors.lastname: Jallut
authors.forename: Y
authors.initials: Y
authors.lastname: Schutz
authors.forename: J P
authors.initials: JP
authors.lastname: Felber
authors.forename: E
authors.initials: E
authors.lastname: Jéquier
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001833:Body Temperature Regulation / Q000187:drug effects; D001835:Body Weight; D002151:Calorimetry; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism*; D004734:Energy Metabolism; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000378:metabolism*; D011446:Prospective Studies; D012044:Regression Analysis
chemical_list: D001786:Blood Glucose; D007328:Insulin; D005947:Glucose